Reducing tobacco-associated lung cancer risk: a study protocol for a randomized clinical trial of AB-free kava
Tobacco use is the leading cause of many preventable diseases, resulting in premature death or disease. Given that the majority of adult who smoke want to stop, this health burden could be significantly reduce...
Source: Trials - Category: General Medicine Authors: Chengguo Xing, John Malaty, Melissa Bou Malham, Anna Maria Abi Nehme, Breanne Freeman, Zhiguang Huo, Roberto Firpi-Morrel and Ramzi G. Salloum Tags: Study protocol Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | General Medicine | Kava | Lung Cancer | Smokers | Study